Quarterly ResultJul 27, 2026, 02:54 PM
Philips Q2 Sales +4%; FY26 Adj. EBITA Outlook Raised to 13.5%-14.0%
AI Summary
Philips reported Q2 2026 comparable sales growth of 4% to EUR 4.4 billion, with Adjusted EBITA margin increasing to 16.4%, significantly boosted by a US tariff refund. While comparable order intake declined 1% due to timing, all business segments contributed to sales growth. The company reiterated its full-year 2026 comparable sales growth outlook and raised its Adjusted EBITA margin and free cash flow outlook, reflecting the impact of the US tariff refund.
Key Highlights
- Q2 comparable sales grew 4% to EUR 4.4 billion.
- Q2 Adjusted EBITA margin was 16.4%, including 4.2% from US tariff refund.
- Q2 Income from operations reached EUR 609 million, including EUR 186 million US tariff refund.
- Full-year 2026 Adjusted EBITA margin outlook raised to 13.5%-14.0%.
- Full-year 2026 Free cash flow outlook raised to EUR 1.5-1.7 billion.
- Diagnosis & Treatment comparable sales increased 2%.
- Connected Care comparable sales increased 2%.
- Personal Health comparable sales increased 8%.
Price Impact
More from PHG